Valproic acid, which inhibits rat brain microsomal ACSL4, reduces arachidonic acid turnover; this suggests a possible mechanism that might account for the efficacy of valproic acid in treating bipolar disorder [36]. The gene discussed is ACSL4; the disease is bipolar disorder.